Trials / Completed
CompletedNCT02425943
Sculptra Aesthetic Post-Approval Study
A Prospective, Open-Label, Multicenter Study to Evaluate the Long-Term Safety of Sculptra®Aesthetic in Immuno-Competent Subjects Stratified by Fitzpatrick Skin Type I-VI)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 867 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Study is designed to assess the long-term safety of Sculptra Aesthetic in immune-competent subjects as a single regimen for correction of nasolabial fold (NLF) contour deficiencies and other facial wrinkles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | injectable poly-L-lactic acid Sculptra Aesthetic |
Timeline
- Start date
- 2015-05-21
- Primary completion
- 2021-05-28
- Completion
- 2021-05-28
- First posted
- 2015-04-24
- Last updated
- 2023-07-27
- Results posted
- 2023-07-27
Locations
18 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02425943. Inclusion in this directory is not an endorsement.